Karnataka, India

Sandhya Ujire

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2005.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandhya Ujire: Innovator in Pharmaceutical Synthesis

Introduction

Sandhya Ujire is a prominent inventor based in Karnataka, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medicine. Her work is recognized for its potential impact on health and wellness.

Latest Patents

Ujire holds a patent for a novel process titled "Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds." This invention discusses a unique method for synthesizing atorvastatin, a compound that serves as an inhibitor of the HMG-CoA reductase. The compound is valuable as a hypolipidemic and hypocholesterolemic agent, which can help manage cholesterol levels in patients.

Career Highlights

Sandhya Ujire is associated with Biocon Limited, a leading biopharmaceutical company. Her role at Biocon has allowed her to work on innovative projects that contribute to the development of effective therapeutic solutions. Ujire's expertise in synthesis processes has positioned her as a key player in her field.

Collaborations

Some of her notable coworkers include Ganesh Sambasivam and Sumitra Srinath. Their collaborative efforts have further enhanced the research and development initiatives at Biocon Limited.

Conclusion

Sandhya Ujire's contributions to pharmaceutical synthesis exemplify the importance of innovation in healthcare. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…